Apyx Medical (APYX) Long-Term Deferred Tax (2010 - 2016)

Apyx Medical's (APYX) quarterly Long-Term Deferred Tax came in at $21000.0 in Q2 2016, down 46.15% on a QoQ basis from $39000.0 in Q1 2016.

Apyx Medical (APYX) Long-Term Deferred Tax (2010 - 2016) Analysis & Trends

Apyx Medical (APYX) has 7 years of Long-Term Deferred Tax data on file, last reported at $21000.0 in Q2 2016.

Quarterly Long-Term Deferred Tax changed N/A year-over-year to $21000.0 in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $21000.0 (changed N/A YoY) and the FY2015 annual result came in at $25000.0, down 99.54% from the prior year.
Long-Term Deferred Tax fell to $21000.0 in Q2 2016, from $39000.0 in the prior quarter.
In the past five years, Long-Term Deferred Tax ranged from a high of $5.4 million in Q4 2014 to a low of $21000.0 in Q2 2016.
A 5-year average of $2.0 million and a median of $1.4 million in 2012 frame the typical range for Long-Term Deferred Tax.
Annual changes were most pronounced in 2013 — Long-Term Deferred Tax soared 89.66% — and 2015, when it plunged 99.54%.
Tracing APYX's Long-Term Deferred Tax over 5 years: stood at $1.8 million in 2012, then jumped by 89.66% to $3.4 million in 2013, then soared by 58.44% to $5.4 million in 2014, then sank by 99.54% to $25000.0 in 2015, then fell by 16.0% to $21000.0 in 2016.
The last three Long-Term Deferred Tax figures came in at $21000.0 (Q2 2016), $39000.0 (Q1 2016), and $25000.0 (Q4 2015), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.24 Bn	193.64 Bn	7.27 Bn
2	Stryker	128.63 Bn	125.15 Bn	4.50 Bn
3	Medtronic	119.19 Bn	109.97 Bn	6.41 Bn
4	Boston Scientific	73.51 Bn	72.97 Bn	3.85 Bn
5	Edwards Lifesciences	52.11 Bn	47.85 Bn	1.35 Bn
6	Dexcom	34.64 Bn	32.70 Bn	830.00 Mn
7	GE HealthCare Technologies	34.01 Bn	31.90 Bn	2.18 Bn
8	Koninklijke Philips	26.40 Bn	23.08 Bn	4.55 Bn
9	Steris	23.14 Bn	22.65 Bn	684.20 Mn
10	Apyx Medical	136.81 Mn	109.19 Mn	8.87 Mn

Download Data